Heart Failure in the 7 Major Markets, Forecast to 2032: Insights into HF Therapeutics Growth, Market Dynamics, and Key Drivers

Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report delves into the Heart Failure (HF) market across the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides a detailed forecast model through 2032. It's a comprehensive analysis of HF therapeutics, encompassing a wide range of factors that will s

Related Keywords

Japan ,Dublin ,Ireland ,Germany ,Italy ,France ,Spain ,United Kingdom ,Eli Lilly ,Johnson ,Novartis ,Astrazeneca ,Amgen ,Boehringer Ingelheim ,Glucose Co ,Novo Nordisk ,Major Markets ,Disease Management ,Pipeline Assessment ,Unmet Needs ,Drug Forecast ,Heart Failure ,Compound Annual Growth Rate ,Sodium Glucose Co Transporter Inhibitors ,Injectable Agents ,Generic Drugs ,Future Players ,Topics Covered ,Market Expansion ,Herapeutics ,Innovative Therapies ,